IDT Australia Limited

ASX:IDT ISIN:AU000000IDT0

Supply of products and provision of research and development and other technical services for the pharmaceutical and allied industries. 
 

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 13408

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article

Institute Of Drug Technology Australia Limited ASX: IDT - Expands Drug Development Relationship With Pfizer - Dr Graeme Blackman, Chairman & Managing Director

🕔1/29/2007 11:07:00 AM 3460

Institute Of Drug Technology Australia Limited (ASX: IDT) - Expands Drug Development Relationship With Pfizer - Dr Graeme Blackman, Chairman & Managing Director; Boardroomradio is pleased to announce that Institute Of Drug Technology Australia Limited (ASX: IDT) has published an audio file.

Read Full Article
###

3,777 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 11) (Last 30 Days: 50) (Since Published: 3777) 

Company Data

    Fax
  • (03) 9801 8773 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Listed
  • 1991/02/18 
  • Homepage
  • www.idtaus.com.au/

More News Results

  • 2025/08/21: FY25 Full Year Profit Results*
  • 2025/08/21: FY25 Appendix 4G and Corporate Governance Statement*
  • 2025/08/21: FY25 Appendix 4E and Annual Report*
  • 2025/08/19: Planned Retirement of the Chief Financial Officer*
  • 2025/08/07: CEO Resignation & Trading Update*
  • 2025/08/05: Trading Halt*
  • 2025/07/17: Agreement with NASDAQ-Listed Gelteq for Dedicated Facility*
  • 2025/07/15: Notification of cessation of securities - IDT*
  • 2025/04/29: Quarterly Revenue Growth of 30% with $62M in Open Proposals*
  • 2025/04/14: Change of Director's Interest Notice - Geoffrey Sam*
*refer to company website